National Institute on Aging; Notice of Closed Meetings, 24901 [2011-10668]

Download as PDF Federal Register / Vol. 76, No. 85 / Tuesday, May 3, 2011 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute on Aging; Notice of Closed Meetings Request for Input To Inform a Possible Surgeon General Action on Prescription Drug Abuse in Youth Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. srobinson on DSKHWCL6B1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Name of Committee: National Institute on Aging Initial Review Group, Behavior and Social Science of Aging Review Committee. Date: June 1–2, 2011. Time: 4 p.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street, Santa Monica, CA 90401. Contact Person: Jeannette L. Johnson, PhD, Scientific Review Officer, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Suite 2c–212, Bethesda, MD 20892, 301–402–7705, johnsonj9@nia.nih.gov. Name of Committee: National Institute on Aging Initial Review Group, Clinical Aging Review Committee. Date: June 2–3, 2011. Time: 6 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street, Santa Monica, CA 90401. Contact Person: Alicja L. Markowska, PhD, DSC, National Institute on Aging, National Institutes of Health, Gateway Building 2c212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–496–9666, markowsa@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: April 25, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–10668 Filed 5–2–11; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 20:39 May 02, 2011 Jkt 223001 National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services (HHS). ACTION: Request for information. The National Institute on Drug Abuse, a Research Institute of the National Institutes of Health, is seeking on behalf of the Department of Health and Human Services information for an anticipated Surgeon General response to the public health problem of prescription drug abuse among youth. SUPPLEMENTARY INFORMATION: Scope of Problem: Prescription drug abuse 1 remains a looming public health threat in this country. Unlike illicit drug use, which has shown a continuing downward trend, prescription drug abuse, particularly of opioid pain medications, has seen a continual rise through the 1990s and has remained stubbornly steady among persons 12 or older during recent years. Most abusers are between the ages of 18 and 25, but younger age groups are also a major concern. Approach: ONDCP highlighted prescription drug abuse in its 2010 National Drug Control Strategy. At that time, ONDCP outlined a plan of action to address the prescription drug abuse problem, which included engaging the Office of the Surgeon General to help bring it needed attention. A multiagency federal work group was formed to follow through on facilitating a Surgeon General response. To date, the work group has received expert input on the state of the science for addressing prescription drug abuse among youth, including from scientific researchers, public health officials, clinicians, and military and law enforcement personnel. Expectations are that a review of the information collected will lead to the issuance of a Surgeon General publication. Potential Areas of Focus: Extent of the problem and its consequences; differences in prescription drug abuse motivations and how they might inform SUMMARY: 1 Prescription drug abuse is defined here as the intentional use of a medication without a prescription; in a way other than as prescribed; or for the experience or feeling elicited. It is used interchangeably with ‘‘nonmedical’’ use, a term employed by many of the National Surveys. This definition does not include use for self-harm (suicide attempts). PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 24901 prevention approaches; availability and adaptability of evidence-based prevention programs; the design of media messages for a wide range of stakeholders; and possible roles for health care professionals, parents, community stakeholders, law enforcement, policymakers, and others addressing this problem. Purpose of Notice: The purpose of this notice is to provide individuals and organizations the opportunity to identify issues and areas of need for consideration as we gather information for an anticipated Surgeon General response to the public health problem of prescription drug abuse among youth. Comments must be in writing and should not exceed 500 words. All comments will receive careful consideration. However, persons and organizations submitting comments will not receive individual responses. DATES: Individuals and organizations interested in providing information must submit their comments on/or before June 2, 2011. Comments received after this date will not be considered. ADDRESSES: Comments may be submitted by any one of the following methods: • Mail: Anna Staton, M.P.A., Office of Science Policy and Communications, National Institute on Drug Abuse, 6001 Executive Boulevard, Suite 5230, MSC 9591, Bethesda, MD 20892–9591; or • E-mail: Send to comments4sg@nih.gov. FOR FURTHER INFORMATION CONTACT: Mary Beth Bigley, Dr.P.H., M.S.N., A.N.P., Acting Director, Office of Science and Communications, Office of the Surgeon General, by telephone at 202–205–5642, or e-mail at Marybeth.Bigley@hhs.gov. Dated: April 27, 2011. Mary Affeldt, Executive Officer, NIDA, National Institutes of Health. [FR Doc. 2011–10735 Filed 5–2–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Office of the Secretary [Docket No. DHS–2011–0019] Privacy Act of 1974; Department of Homeland Security United States Coast Guard—DHS/USCG–002 Employee Assistance Program Records System of Records AGENCY: E:\FR\FM\03MYN1.SGM Privacy Office, DHS. 03MYN1

Agencies

[Federal Register Volume 76, Number 85 (Tuesday, May 3, 2011)]
[Notices]
[Page 24901]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10668]



[[Page 24901]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Initial Review 
Group, Behavior and Social Science of Aging Review Committee.
    Date: June 1-2, 2011.
    Time: 4 p.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street, 
Santa Monica, CA 90401.
    Contact Person: Jeannette L. Johnson, PhD, Scientific Review 
Officer, National Institute on Aging, National Institutes of Health, 
7201 Wisconsin Avenue, Suite 2c-212, Bethesda, MD 20892, 301-402-
7705, johnsonj9@nia.nih.gov.

    Name of Committee: National Institute on Aging Initial Review 
Group, Clinical Aging Review Committee.
    Date: June 2-3, 2011.
    Time: 6 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street, 
Santa Monica, CA 90401.
    Contact Person: Alicja L. Markowska, PhD, DSC, National 
Institute on Aging, National Institutes of Health, Gateway Building 
2c212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301-496-9666, 
markowsa@nia.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: April 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-10668 Filed 5-2-11; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.